Program Highlights
Nordic Life Science Days offers a thoughtfully curated program that provides a preview of emerging developments in the life science industry
A program being built around strategic shifts
NLSDays 2026 will shine a light on the latest trends shaping the global life science industry while continuing to elevate Nordic success stories. This year’s program is being developed around the forces redefining our industry — with a strong focus on strategic insights and real-world examples, including:
- Breakthrough developments in CNS
- The growing role of strategic VC arms
- Investment opportunities within the healthtech sector
By bringing together global and Nordic perspectives, the 2026 program will explore how companies can navigate complexity, secure capital, and build competitive advantage in a rapidly changing environment.
Plan your week at NLSDays
Arrival:
Arrive in Stockholm by Monday, September 7, to make the most out of NLSDays 2026. You can collect your badge from 14:00 onwards.
Departure:
The program and partnering will end at 18:00 on Wednesday, September 9. Side events are scheduled for Thursday, September 10, exclusively for our international delegations.
2026 Session Topics
This year’s topics highlight the event’s role in connecting global and Nordic perspectives across the life science ecosystem — bringing together biotech innovators, investors, pharma leaders, and healthtech pioneers to explore breakthrough science, evolving investment strategies, and the partnerships shaping the future of healthcare.
Breakthrough Developments in CNS
Supersession
As the global burden of neurological and psychiatric disorders continues to rise, innovation in central nervous system (CNS) research has become one of the most urgent and promising frontiers in life science. This session highlights the latest advances in neuroscience, novel therapeutics, and precision approaches targeting central nervous system disorders. During the session, experts will discuss emerging science, clinical milestones, and the outlook for CNS innovation.
The Growing Role of Strategic VC Arms
Supersession
As biotech financing becomes increasingly competitive and partnership-driven, strategic venture capital is playing a growing role in shaping innovation and company growth. Strategic investors create value beyond capital through partnerships, insight, and global reach. During this session, panelists will discuss how corporate venture capital is influencing early-stage innovation, investment strategy, and long-term growth across biotech and healthcare.
Investment Opportunities within the Healthtech Sector
Supersession
As healthcare systems worldwide accelerate digital transformation, healthtech continues to attract strong investor interest across a rapidly expanding range of technologies and business models. This discussion explores market trends, scalable business models, and what investors are prioritizing in today’s evolving healthtech landscape. Panellists will identify high-growth opportunities across digital health, diagnostics, AI-enabled platforms, and innovative care delivery models.
The New Global Dealmaking Map: China’s Innovation Surge and the Future of Biopharma Partnerships
Supersession
China has rapidly emerged as one of the world’s most dynamic sources of biotech innovation, reshaping global partnering, licensing, and investment strategies. This super session at Nordic Life Science Days 2026 brings together international pharma leaders, investors, and biotech executives to explore how cross-border dealmaking is evolving, what is driving the rise of Chinese innovation, and how Nordic and global companies can position themselves in this increasingly interconnected ecosystem.
Maze Runner or Straight Runner – transforming innovation funding from Maze to Autobahn
Supersession
This panel will explore how Europe can unlock its innovation potential by strengthening collaboration between academia, SMEs and capital. It will address two key areas: how to mobilize and scale private investment, and how to improve the efficiency and impact of existing EU funding. Through a practical, business-driven dialogue, the discussion will focus on accelerating commercialization, reducing structural barriers, and enhancing Europe’s global competitiveness.
Where Nordic life science meets the world
Conference topics are carefully selected to reflect current trends in the life science industry, focusing on areas where Nordic excellence aligns with the global interest.
The two-day conference features a variety of engaging session formats
Supersessions
are panel discussions addressing hot topics in life science. Each session features representatives from pharma, investment, biotech, and medtech companies discussing the latest industry advancements.
Spotlight Panels
offer companies a platform to lead high-level discussions on their specific area of expertise. These 30-minute sessions feature a moderator-led overview followed by a dynamic exchange among invited experts.
Global Insights and Company Presentations
provide the opportunity for international delegations, regional clusters and individual companies to highlight their unique strengths and market positioning.
Pitch Competition
gives early-stage companies a chance to present their ventures on a high-profile stage.
Poster Session
invites academics and startups to showcase their innovation potential in a visual and engaging format.
Inspired by our program?
Don’t miss out on these valuable insights and networking opportunities – Registrations is now open